(Fox News) The U.S. Food and Drug Administration is increasing its oversight of Chinese manufacturers of pharmaceutical ingredients to improve the safety of the U.S. drug supply chain, the director of the agency’s China office, Christopher Hickey, said on Thursday.
Hickey was one of several witnesses who testified before a hearing of the U.S.-China Economic and Security Review Commission, which monitors and investigates the national security implications of bilateral trade and economic relations between the two countries.
Armed with new legal authority and additional funding, the FDA has begun adding staff and inspectors in China, but the process is not without challenges, Hickey said.
